BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7102227)

  • 1. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
    Zapletálek M; Zbytovský J; Kudrnová K
    Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
    Ovuga E
    East Afr Med J; 1985 Feb; 62(2):79-81. PubMed ID: 4042927
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of therapy-refractory depressions].
    Pöldinger W; Alac S; Krebs-Roubicek E
    Act Nerv Super (Praha); 1982 May; 24(2):55-62. PubMed ID: 6125075
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of depression with intravenous infusions of clomipramine and maprotiline].
    Bogdanowicz E; Kalinowski A; Swiecicki L
    Psychiatr Pol; 1991; 25(3-4):19-24. PubMed ID: 1821972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients.
    Fähndrich E
    Pharmacopsychiatria; 1983 Nov; 16(6):179-85. PubMed ID: 6665027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
    Ravizza L
    Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological predictors of success of antidepressant drug therapy.
    Fähndrich E
    Psychiatr Dev; 1987; 5(2):151-71. PubMed ID: 3628243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of drug-resistant depression by intravenous administration of antidepressants].
    Kielholz P
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(4):53-6. PubMed ID: 1975146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Our experiences in the treatment of pharmacoresistent depressions with maprotiline].
    Rektor L; Misaurec J; Horká E; Cerná V
    Act Nerv Super (Praha); 1982 May; 24(2):101-5. PubMed ID: 7102221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of therapy-resistant depressions. Results of combined infusion treatment].
    Kielholz P; Terzani S; Gastpar M; Adams C
    Schweiz Med Wochenschr; 1982 Aug; 112(31-32):1090-5. PubMed ID: 7134934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of maprotiline hydrochloride for treatment of depression.
    Clin Ther; 1984; 6(2):155-62. PubMed ID: 6367987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
    Drago F; Motta A; Grossi E
    J Int Med Res; 1983; 11(2):78-84. PubMed ID: 6343154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of maprotiline on target symptoms of depressive states].
    Faltus F
    Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with maprotiline.
    Kabes J; Dostal T; Roth Z
    Act Nerv Super (Praha); 1982 May; 24(2):93-8. PubMed ID: 7048837
    [No Abstract]   [Full Text] [Related]  

  • 19. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
    Ridges AP
    Postgrad Med J; 1977; 53 Suppl 4():24-9. PubMed ID: 341107
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of treatment-resistant depression without ECT (author's transl)].
    Kielholz P; Terzani S; Gastpar M; Adams C
    Dtsch Med Wochenschr; 1981 May; 106(21):671-3. PubMed ID: 6113126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.